Showing 3511-3520 of 4062 results for "".
- Rayner Announces 1,000 IOLs Recorded on RayPRO Digital Platformhttps://modernod.com/news/rayner-announces-1000-iols-recorded-on-raypro-digital-platform/2479436/Rayner announced that it has achieved the milestone figure of 1,000 intraocular lenses recorded on RayPRO, its digital patient reported outcomes platform. Launched at ASCRS in 2019 for ophthalmic surgeons who perform cataract procedures, RayPRO is a web-based and mobile digital platform th
- IrisVision Names Naeem Kayani President & Chief Operating Officerhttps://modernod.com/news/irisvision-names-naeem-kayani-president-chief-operating-officer/2479431/IrisVision announced the addition of Naeem Kayani to serve as President and Chief Operating Officer. Launched in 2017, IrisVision’s flagship consumer product employs breakthrough, smart software lens technology that leverages functional areas of the eyes to restore vision instantly. Design
- Oyster Point Pharma Names Donald Santel as Chairman of the Board of Directorshttps://modernod.com/news/oyster-point-pharma-names-donald-santel-as-chairman-of-the-board-of-directors/2479427/Oyster Point Pharma announced the appointment of Donald Santel as non-executive Chairperson and a Director of the company and a member of the Compensation Committee. Mr. Santel joined the Board on July 30, 2021, and will take over as Chairperson as Ali Behbahani, MD, steps down as Ch
- Nickelodeon and OneSight Team Up for Kids Eye Health Campaignhttps://modernod.com/news/nickelodeon-and-onesight-team-up-for-kids-eye-health-campaign/2479424/More than 230 million kids around the world under the age of 15 lack access to the glasses they need. To make a positive impact on kids’ eye health globally, Nickelodeon International’s “Together for Good” and OneSight, a global vision nonprofit, announced their partnership on a new, multi-territ
- Topcon Announces New Executive Appointmentshttps://modernod.com/news/topcon-announces-new-executive-appointments/2479425/Topcon Healthcare announced the appointment of several new members to the US executive team, as well as the promotion of key employees. Effective October 1, 2021, Peter Larsen will become the President of Topcon Medical Systems, succeeding John Fujita, who will be returning to Japan for a
- Aurion Biotech Announces IOTA Cell Therapy Trialhttps://modernod.com/news/aurion-biotech-announces-iota-cell-therapy-trial/2479415/Aurion Biotech announced preliminary findings from its IOTA trial, conducted in November 2020 and in May of this year, at the Clínica Quesada in San Salvador, El Salvador. In the IOTA trial, 50 patients diagnosed with corneal endothelial disease were treated with a transformational cell th
- New Data Presented on the Safety and Efficacy of Investigational AGN-190584 as a Potential Novel Treatment for Presbyopiahttps://modernod.com/news/new-data-presented-on-the-safety-and-efficacy-of-investigational-agn-190584-as-a-potential-novel-treatment-for-presbyopia/2479409/Allergan announced new data, including the full results from the phase 3 GEMINI 1 clinical study, evaluating the efficacy, safety and tolerability of investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia. Multiple data presentations at the 2021
- BVI Announces Collaboration With BeyeOnics Visionhttps://modernod.com/news/bvi-announces-collaboration-with-beyeonics-vision/2479411/BVI announces a collaboration with Israel-based BeyeOnics Vision, a maker of in head-mounted display, digital data, and imaging processing. BeyeOnics Vision has been developing BeyeOnics 1, which the company describes as the first and only ophthalmic digital imaging system replacing the op
- LumiThera: Data Show Valeda Treatments Improve Vision and Retinal Function in Dry AMD patientshttps://modernod.com/news/lumithera-data-show-valeda-treatments-improve-vision-and-retinal-function-in-dry-amd-patients/2479408/LumiThera, a commercial stage medical device company offering a photobiomodulation (PBM) treatment for ocular damage and disease, announced the final topline data from the ELECTROLIGHT pilot study in intermediate dry AMD patients. A total of 23 eyes from 15 subjects with dry AMD were enro
- Ocular Therapeutix To Present Clinical Data at ASCRShttps://modernod.com/news/ocular-therapeutix-to-present-clinical-data-at-ascrs/2479403/Ocular Therapeutix announced multiple scientific presentations at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting being held July 23-27, 2021 in Las Vegas. “At ASCRS, we will be presenting data on multiple programs we are advancing in the clinic as well